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Abstract
The SLC45A2 gene encodes a Membrane-Associated Transporter Protein (MATP). Muta-
tions of this gene cause oculocutaneous albinism type 4 (OCA4). However, the molecular
mechanism of its action in melanogenesis has not been elucidated. Here, we discuss the
role of MATP in melanin production. The SLC45A2 gene is highly enriched in human mela-
nocytes and melanoma cell lines, and its protein, MATP, is located in melanosomes. The
knockdown of MATP using siRNAs reduced melanin content and tyrosinase activity without
any morphological change in melanosomes or the expression of melanogenesis-related
proteins. Interestingly, the knockdown of MATP significantly lowered the melanosomal pH,
as verified through DAMP analysis, suggesting that MATP regulates melanosomal pH and
therefore affects tyrosinase activity. Finally, we found that the reduction of tyrosinase activi-
ty associated with the knockdown of MATP was readily recovered by copper treatment in
the in vitro L-DOPA oxidase activity assay of tyrosinase. Considering that copper is an im-
portant element for tyrosinase activity and that its binding to tyrosinase depends on melano-
somal pH, MATPmay play an important role in regulating tyrosinase activity via controlling
melanosomal pH.
Introduction
Melanin production in humans is an essential cellular response in the eyes, hair and skin to
protect the cells from harmful ultraviolet light, reducing the risk of melanoma progression [1–
4]. Melanin is commonly produced by melanocytes that originated from the neural crest and
reside in the basal layer of the epidermis [5]. Skin color determinant melanin is divided into
two groups, eumelanin and pheomelanin, and functions to protect the DNA from damage by
absorbing ultraviolet light [6, 7]. Eumelanin is a black or brown color and is responsible for
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black or brown human skin and hair. Pheomelanin is a reddish color and is responsible for red
hair [6, 8].
The lack of or reduction in melanin production in skin and hair is called albinism [9]. Mela-
nin deficiencies due to poor melanin production in the eyes, hair and skin, associated with im-
paired vision and skin that is easily damaged by sunlight, is called oculocutaneous albinism
(OCA) [9]. This condition commonly results from alterations in melanogenesis-related pro-
teins or mutations in tyrosinase (OCA1), pink-eyed dilution protein (OCA2), tyrosinase-relat-
ed protein 1 (OCA3) and membrane-associated transporter protein (OCA4) [10, 11]. There
are severe forms of albinism involving pathological alterations, such as Hermansky-Pudlak
syndrome (HPS) and Chediak-Higashi syndrome (CHS) [12]. HPS is an autosomal recessive
disorder caused by mutations in HPS family members involving bleeding and cellular storage
disorders [12]. TheHPS gene encodes a protein that plays crucial roles in organelle biogenesis
in normal cells, which is also important in melanosome production. The loss of its function fol-
lowing a mutation causes albinism [12]. In a similar fashion, the CHS1 gene participates in the
regulation of lysosomal trafficking in normal cells, including melanocytes. The loss of its func-
tion by a mutation leads to Chediak-Higashi syndrome and albinism [13, 14].
The OCA4 gene encodes a sugar transporter-like membrane protein known as the Mem-
brane-Associated Transporter Protein (MATP) [15, 16]. MATP, encoded by AIM1 in medaka
[17], is also known as SLC45A2 and is a member of the solute carrier family 45A. The SLC45
family consists of four members, SLC45A1, SLC45A2 (MATP), SLC45A3, and SLC45A4 [18],
and has high similarity to a recently identified functional animal sucrose transporter (SCRT) in
Drosophila melanogaster [19]. SCRT is similar to plant sugar uptake transporters (SUTs) con-
taining a typical sucrose transporter sequence (RxGRR) [19]. Interestingly, the expression of
SCRT is enriched in melanin-containing organelles as well as in the gastrointestinal tract, sug-
gesting a possible role for sucrose transporters in melanin synthesis [19]. In the SLC45A2 gene,
a T-to-C transition in codon 435 and a G-to-A transition in codon 153, which result in S435P
and D153N mutations, respectively, are related to OCA4, a hypopigmentation disorder with al-
terations in skin/hair/eye pigmentation [20]. In addition, a pigmentation variation caused by
the single nucleotide polymorphisms F374L and E272K in MATP has been reported [21]. In a
study of primary melanocytes isolated frommice deficient in the underwhite (uw) gene, a homo-
logue of humanMATP, correct tyrosinase processing but not intracellular trafficking to the me-
lanosomes was observed [16]. Although the functional relevance of MATP in melanogenesis is
strongly suggested via the phenotypic analysis of humans harboring mutations in the SLC45A2
gene or mice deficient in the uw gene, a molecular mechanism to explain howMATP regulates
melanin biosynthesis in humans has not been elucidated.
In this study, we verified the role of MATP in melanogenesis using human primary melano-
cytes and melanoma cells. Among SLC45A family genes, only SLC45A2 was enriched in the
tested human melanocytes and melanoma cells and its protein, MATP, was located in melano-
somes. The knockdown of MATP using siRNA reduced melanin content and tyrosinase activi-
ty by acidifying the pH of the melanosomes. Finally, we proposed a model explaining how
MATP regulates melanogenesis.
Results
The SLC45A2 transcript is highly expressed in human melanoma cells
and primary melanocytes
At least 4 transcripts of the SLC45A family have been described in the human genome [18].
Despite their high functional and structural similarity, SLC45A family members, other than
SLC45A2, have not been studied in relation to pigmentation. We determined the expression
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pattern of the SLC45A family members in various pigmented cells, human melanoma cell lines
and primary melanocytes and in several non-pigmented cells using quantitative real-time poly-
merase chain reaction (qRT-PCR). Among the SLC45A members, the SLC45A2 transcript was
highly enriched in the majority of the melanoma cell lines (Fig 1A). The expression pattern of
SLC45A2 was determined in normal melanocytes derived from Caucasians and Asians (Fig
1B) but not in non-melanogenic cells, keratinocytes, fibroblasts, or HeLa cells (Fig 1C). Com-
pared to SLC45A2, the expression of SLC45A3 and SLC45A4 was highly enriched in keratino-
cytes and HeLa cells and SLC45A1 in fibroblasts (Fig 1C). The expression of MATP protein,
which is encoded by the SLC45A2 gene, was analyzed by western blotting with anti-MATP an-
tibodies. A major band detected by three different antibodies was approximately 58 kDa in mo-
lecular weight, which is very close to the size of MATP protein (approximately 58.3 kDa)
calculated from amino acid sequence, and this band was not detected in HeLa cells in all analy-
ses (Fig 1D and S1 Fig). These results indicated that among the SLC45A family members,
SLC45A2 is specifically expressed in human melanocytic lineages, such as melanoma cell lines
and melanocytes, and could play a specific role(s) in melanogenesis.
The MATP protein is located in melanosomes
MATP is associated with OCA4 and has been proposed as a melanosomal protein [22]. The
LC/MS data implied that the MATP protein is located in the melanosomes [23]. Using an anti-
MATP antibody, which detected the MATP protein as a single major band in western blot
analysis (Fig 1D, arrowhead) and reduced the signal fromMATP after being pre-absorbed by
MATP antigen (Fig 2A), we performed confocal microscopic analysis to observe the cellular lo-
cation of the endogenous MATP protein. Its expression was partially merged with the melano-
somal markers TA99 and HMB45 (Fig 2B and S2 Fig, insets, arrow heads) and with EEA1, an
endosomal marker (Fig 2C, first panel), but not with LAMP1, a lysosomal marker (Fig 2C, sec-
ond panel), or TNG46, a Golgi apparatus marker (Fig 2C, third panel). These data indicate that
the MATP protein was specifically present in both endosomes and melanosomes but not in the
Golgi apparatus or the lysosomes, implying its specific involvement in melanogenesis.
The knockdown of MATP using siRNA (MATP-KD) reduces melanin
production
To examine the effect of the MATP protein in melanogenesis, we knocked down endogenous
MATP using siRNA in MNT-1 cells. MATP-KD did not alter cellular morphology (Fig 3A)
but reduced the melanin content (Fig 3B) and the L-DOPA oxidase activity of tyrosinase (Fig
4). We examined the expression of the melanogenesis-related genes and proteins after MATP
deletion. Treatment with MATP siRNA reduced the mRNA and protein levels of endogenous
MATP compared to vehicle or scrambled siRNA-treated controls (Fig 3C and S3 Fig). Interest-
ingly, the mRNA and protein levels of melanogenesis-related genes, such as tyrosinase, tyrosi-
nase related protein 1 (TYRP-1), premelanosome protein 17 (PMEL17) and microphthalmia-
associated transcription factor (MITF), were not altered by MATP-KD (Fig 3C and S3 Fig).
We also analyzed whether there was any change in N-glycan modification in tyrosinase be-
cause N-glycosylation is an important factor for tyrosinase activity, which was reduced in the
MATP-KD cells (Fig 4). We did not observe any difference in N-glycan modification in
MATP-KD cells compared to vehicle or scrambled siRNA-treated cells before and after the
EndoH treatment (S4 Fig), suggesting that another mechanism is involved in the reduction of
tyrosinase activity in MATP-KD cells. We used electron microscopy to detect changes in the
intracellular vesicles, especially the melanosomes. Compared to scrambled siRNA-treated con-
trol cells, in which the melanized melanosomes (stage III or IV) were frequently observed and
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Fig 1. The SLC45A2 transcript is highly expressed in humanmelanoma cells and primarymelanocytes. Expression of the SLC45A transcripts in
various humanmelanoma cell lines (A), normal melanocytes from Caucasians and Asians (B), and human non-melanogenic skin cells (C) were examined by
RT-qPCR. The data are representative of three independent experiments. (D) The expression of the MATP protein in human cells was analyzed by
immunoblotting with an anti-MATP antibody. The arrowhead indicates the MATP protein. The data are representative of three independent experiments.
doi:10.1371/journal.pone.0129273.g001
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Fig 2. The MATP protein is located in the melanosomes. (A) MNT-1 cells were stained with anti-MATP antibody before (MATP) or after antigen pre-
absorbance (Pre-absorbed) for 5 min prior to adding an anti-MATP antibody. (B) MNT-1 cells were stained with anti-TA99 or-HMB45 (a melanosomal protein)
antibodies together with an anti-MATP antibody. The insets are magnified, and the co-localization of MATP and each melanosomal marker is indicated by
arrowheads. Scale bars = 10 μm. (C) Cells were stained with anti-EEA1, anti-LAMP1, or anti-TNG46 antibodies to detect the endosomes, the lysosomes, or
the Golgi apparatus, respectively, together with an anti-MATP antibody. These representative images were captured by confocal microscopy. Scale
bars = 10 μm.
doi:10.1371/journal.pone.0129273.g002
MATP Controls Melanosomal pH
PLOSONE | DOI:10.1371/journal.pone.0129273 June 9, 2015 5 / 16
Fig 3. The knockdown of MATP using siRNA reducesmelanin production. (A) The representative microscopic images after each siRNA treatment for 4
days. (B) The color of the cell lysates from 2 x 105 MNT-1 cells was monitored after each treatment, and the melanin contents were measured by measuring
the absorbance at 450 nm. The data are representative of three independent experiments (*, P < 0.05). (C) The expression level of melanogenesis-related
proteins in MNT-1 cells was analyzed by immunoblotting with the appropriate antibodies. TYR, tyrosinase; TYRP-1, tyrosinase related protein-1; PMEL17,
premelanosome protein 17. (D) Electron microscopy analysis. The white and black arrowheads indicate mature (stage III or IV) and early (stage II)
melanosomes, respectively. II, stage II melanosome; III, stage III melanosome; IV, stage IV melanosome.
doi:10.1371/journal.pone.0129273.g003
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there were few immature melanosomes (Fig 3D, scrambled siRNA, white arrowheads vs. black
arrowheads), the cells treated with MATP siRNA displayed mostly immature, poorly mela-
nized melanosomes (Fig 3D, MATP siRNA, black arrowheads) without any morphological
changes. These results indicate that MATP in the melanosomes is closely related to melanin
production, and thus, the loss of MATP increases the poorly pigmented early melanosomes.
MATP regulates melanosomal pH
Considering that MATP is predicted to be a putative sugar transporter that utilizes the proton
gradient, and melanosomal pH can be directly affected by changes in the proton gradient, we
examined whether melanosomal pH changed after treatment with MATP shRNA. We mea-
sured the melanosomal pH using a DAMP assay in MNT-1 cells stably expressing scrambled
or MATP shRNAs. In the MATP-KD cells, the DAMP signal, which indicates low pH, was
much stronger than that in the scrambled control cells (Fig 5A and 5B). We co-stained the cells
with anti-DNP and anti-HMB45 antibodies for DAMP and melanosomes, respectively, and
found that both signals were well merged (Fig 5C). These data suggest that MATP-KD acidifies
the melanosomal pH, which is associated with lowered tyrosinase activity. Tyrosinase is a rep-
resentative metalloprotein requiring a copper ion as a cofactor; metal coordination into pro-
teins is sensitive to pH. We hypothesize that the acidification of melanosomal pH by
MATP-KD could inhibit the incorporation of copper into tyrosinase and thus reduce tyrosi-
nase activity. To test this hypothesis, we knocked down the endogenous MATP using siRNA in
MNT-1 cells and performed the in vitro L-DOPA oxidase activity assay of tyrosinase using cell
lysates with or without copper sulfate. The copper treatment completely recovered the tyrosi-
nase activity that was significantly reduced in MATP-KD cells (Fig 4), suggesting that the re-
duced tyrosinase activity in MATP-KD cells is due to improper copper binding to tyrosinase
Fig 4. Copper treatment recovers the L-DOPA oxidase activity of tyrosinase in MATP-KD cells.MNT-1 cells were treated with each siRNA for 2 days.
The lysates were treated with or without 1 mM CuSO4 for 5 min before incubating with 2 mg/ml L-DOPA for 1 hour, after which the absorbance at 450 nm was
measured. The data are representative of three independent experiments (***, P < 0.005).
doi:10.1371/journal.pone.0129273.g004
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under the acidic conditions in melanosomes and that the acidic conditions are due to MATP
deletion.
Discussion
We investigated the role of the MATP protein in melanogenesis. Among the SLC45A gene fam-
ilies, only the SLC45A2 gene, encoding the MATP protein, is enriched in melanotic cells. In
Fig 5. The knockdown of MATP acidifies the melanosomal pH. (A) MNT-1 cells stably expressing scrambled or MATP shRNAs were treated with the pH
indicator DAMP for 30 min. An anti-DNP antibody was used to detect DAMP by fluorescence microscopy. Scale bars = 200 μm. (B) The fluorescence
intensity was calculated with ImageJ software (http://rsbweb.nih.gov/ij/download.html). The data are representative of three independent experiments (*,
P < 0.05). (C) MNT-1 cells stably expressing scrambled or MATP shRNAs were co-stained with anti-DNP and anti-HMB45 antibodies after DAMP treatment
for 30 min and then visualized by confocal microscopy. Each inset was magnified. Scale bars = 10 μm.
doi:10.1371/journal.pone.0129273.g005
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MATP-KD generated by siRNA, melanin production was down-regulated and the number of
poorly pigmented melanosomes increased, without significant alterations in the expression of
the melanogenesis-related genes and the morphology of the melanosomes. Simultaneously, the
MATP-KD was associated with reduced tyrosinase activity. A DAMP assay demonstrated that
MATP-KD lowered the melanosomal pH, which may affect tyrosinase activity. Tyrosinase ac-
tivity was readily recovered by copper treatment, suggesting that MATP can have an effect on
tyrosinase activity by maintaining the proper melanosomal pH for copper to bind to tyrosinase.
Finally, we proposed a model explaining howMATP acts as a transporter to regulate melano-
somal pH and thus tyrosinase activity (Fig 6).
A previous study using melanocytes derived from uw/uwmice revealed that the melano-
cytes 1) had an abnormally large and more dendritic morphology, 2) continuously secreted
dark vesicles containing tyrosinase, TYRP-1 and TYRP-2, 3) possessed tyrosinases with only
20% of the activity of tyrosinases from wild type melanocytes, and 4) had swollen and poorly
melanized melanosomes [22]. Here, we found that MATP-KD reduced tyrosinase activity and
induced poorly melanized melanosomes, which is consistent with the results shown for the
uw-mutant melanocytes. However, in our experiments, no significant morphological changes
or secreted dark vesicles were found (Fig 3A). In addition, swollen melanosomes were not de-
tected by electron microscopy (Fig 3D). These findings may result from cell type differences
(mouse vs. human) and/or incomplete knockdown efficiency. Human melanocytes are distinct
from mouse melanocytes. Briefly, mouse melanocytes are located in the hair bulb or bulge, but
human melanocytes exist in the basal layer of the skin epidermis, including the hair bulb or
bulge [24, 25]. Identical stimuli sometimes lead to different cellular responses depending on
the cell type [24, 25]. In this study, we used a siRNA system to knockdown MATP. Although
MATP siRNA was transfected and efficiently knocked down the endogenous SLC45A2 tran-
script, thereby reducing the protein level, approximately half of the SLC45A2 transcript was
still expressed (S3 Fig), which might result in partial phenotypic effects.
The melanosomal pH is regulated by “pumps” and “transporters” [26]. Pumps use ATP to
move substrates to an opposite substrate gradient across a membrane. The V-ATPases that me-
diate proton influx across the membrane to regulate melanosomal pH have been previously re-
ported [26]. Transporters facilitate substrate movement across the membrane via two energy
sources: one is a substrate gradient and the other is a proton gradient generated by the
V-ATPases [27, 28]. Given that MATP has a sucrose transporter motif, but not an ATP biding
motif, it was assumed that MATP is a transporter and not a pump [16]. As a transporter,
MATP seems to utilize the proton gradient to transport its putative sugar-like substrate as
demonstrated in the result that MATP-KD led to an acidic melanosomal pH (Fig 5) and as sug-
gested in our model (Fig 6). This result is consistent with a recent report, which claims that
MATP transports sucrose via a proton-coupled transport mechanism when heterologously ex-
pressed in Saccharomyces cerevisiae [29]. The sugar substrate of MATP may be supplied by re-
versible reactions of glycosylation on many vesicular and secretory proteins because the serial
attachment and detachment of sugars is an essential step of protein glycosylation and many di-
saccharides are generated in this process [30]. Therefore, it is possible that as a proton/sugar
symporter, MATP transports these sugars from the melanosome to the cytoplasm using a pro-
ton gradient generated by a proton pump. This putative MATP transporting mechanism is
similar to that of the plant sucrose/proton symporters, with which MATP shares a high amino-
acid identity [16,17,19]. However, other groups proposed a model in which MATP imports su-
crose into the melanosome to reduce the hypotonic stress induced by tyrosine polymerization
to melanin [18, 29]. There is no doubt that the osmotic status within the melanosome is
changed during melanization, and several melanosomal pumps or transporters, including
MATP and other cation/proton antiporters (for example, sodium/hydrogen exchangers) [31],
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Fig 6. Schematic models of MATP function as a putative transporter in regulatingmelanosomal pH in
normal and OCA4 conditions. Under normal conditions, MATP elevates the melanosomal pH by
functioning as a transporter using a proton gradient. Under this condition, copper can bind to tyrosinase (Cu-
Tyrosinase), resulting in active tyrosinase. In OCA4melanosomes, MATP does not function properly and the
melanosomal lumen becomes acidic. Under this condition, copper cannot incorporate into tyrosinase and
tyrosinase activity is reduced. Apo-Tyrosinase, tyrosinase without copper; Cu-Tyrosinase, tyrosinase
with copper.
doi:10.1371/journal.pone.0129273.g006
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may work together to regulate melanosomal pH and to maintain homeostasis within the mela-
nosome for a step-wise melanogenesis. siRNA treatment targeting the potassium-dependent
sodium calcium exchanger reduces melanin production [32]. Together with our results, both
sugar and cation appear to be crucial for melanogenesis, and it may be possible that the expres-
sion levels and patterns of the transporters are distinct dependently on the stage of melano-
some maturation. Further studies, such as chasing the osmolytes within the melanosome
before and after MATP-KD, will provide more precise information regarding the involvement
of MATP in substrate transport and thus in melanogenesis. In addition, under an electron mi-
croscope, we observed that the melanosomes in MATP-KD cells were mostly stalled at stage II.
It would also be interesting to test if MATP can directly regulate the maturation process of me-
lanosomes by controlling the sugar-induced melanosomal osmotic potential as suggested pre-
viously [33, 34].
Copper ions are imported into the cytoplasm via the copper transporters, which belong to
the SLC31 family on the plasma membrane; are immediately bound by intracellular chaper-
ones; and are then transferred to other molecules, such as ATP7A on melanosomes, to activate
tyrosinase [35, 36]. Copper ions are present as Cu(I) in those steps because endogenous reduc-
tases and components residing on the cell surface reduce copper ions prior to their transporta-
tion into the cytoplasm, and the cytoplasm itself prefers the reducing condition [35]. Unlike
the cytoplasm, we speculate that within the melanosome, Cu(II) may be dominant compared
with Cu(I) because the melanosomal lumen is oxidative to support melanin production [37];
therefore Cu(II) could be present in the active center of tyrosinase. To activate tyrosinase in
this condition, Cu(II) should be reduced to Cu(I), and the initial intermediate L-DOPA may
play a role as a reductor, resulting in the switch from Cu(II) to Cu(I) within the active site of ty-
rosinase. We showed that MATP-KD lowered the melanosomal pH (Fig 5). In this condition,
tyrosinase activity was decreased (Fig 4, left panel), and the decreased tyrosinase activity was
recovered when copper was exogenously introduced into the cell lysates (Fig 4, right panel). Be-
cause the acidic pH could alter the charge status of the amino acids, for example, histidine in
the active site of tyrosinase, which in turn could alter the incorporation of the metal ion into
that site and the subsequent tyrosinase activity, we assume that copper (perhaps Cu(II)) was
not properly incorporated into tyrosinase within the melanosomes in MATP-KD cells. For the
in vitro L-DOPA oxidase activity assay, we lysed the MATP-KD cells using a neutral pH lysis
solution in which cytosolic copper ions could bind to many other cellular proteins, including
tyrosinase, causing the depletion of available copper ions for tyrosinase. We supplied CuSO4 in
the in vitro L-DOPA oxidase activity assay to mimic the melanosome luminal condition, where
Cu(II) may be preferentially present. Once the pH is neutral, the incorporation of Cu(II) into
the tyrosinase active site is normal, and the switch from Cu(II) to Cu(I) in the active center of
tyrosinase can be mediated by exogenously added L-DOPA, as proposed in normal melano-
somes. Some portion of Cu(II) might be reduced to Cu(I) before being incorporated into apo-
tyrosinase in the in vitro assay system for two reasons: 1) a sufficient amount of L-DOPA was
supplied as a substrate; 2) the cell lysates used in this assay might contain proteins and cellular
organic compounds with reducing potential, such as glutathione. Although we speculate that
Cu(II) may be dominant compared with Cu(I) within normal melanosomes and the low mela-
nosomal pH in the MATP-KD cells could affect the incorporation of copper ions, it is difficult
to precisely measure the portion of Cu(II)/Cu(I) and thus definitively describe the status of
copper ions in normal or OCA4 melanosomes. Therefore, Cu, rather than CuI(I) or CuII(II), is
a better description in this model (Fig 6).
The pH is a well-known factor that is crucial for melanin synthesis in many aspects. In early
stage melanosomes, the acidic pH contributes to stabilize L-DOPA by preventing auto-oxida-
tion and the elevating pH according to melanosome maturation optimizes the tyrosinase
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activity for melanin production [37–39]. Considering that an acidic melanosomal pH reduces
tyrosinase activity and prevents L-DOPA oxidation [26, 39], the MATP-KD could influence on
melanogenesis not only by inhibiting tyrosinase activity via altering copper incorporation but
also by changing the portion of L-DOPA. L-DOPA, together with L-tyrosine, plays roles as a
substrate for melanogenesis and as a hormone-like activator of the process [40, 41]. The altered
L-DOPA level by MATP-KD may also affect on the endogenous level of melanogenesis. In dif-
ferent culture media, different concentrations of L-tyrosine are included. As L-tyrosine and
L-DOPA are activators of melanogenesis, the different levels of L-tyrosine due to different
media or stimuli used may also affect the endogenous level of melanogenesis and thus the effec-
tive level of MATP-KD. It may be worth testing the effect of MATP-KD in other melanoma
cell lines or primary melanocytes, which are cultured under different medium conditions, to
test this possibility.
In conclusion, we showed that MATP is highly expressed in melanocytic lineages, is located
in the melanosome, and is involved in maintaining the proper melanosomal pH to allow the
correct incorporation of copper ions into the tyrosinase active site. These findings reveal a
mechanism explaining how the MATP protein plays a role in melanin production and, by ex-
tension, how its mutation is associated with OCA4, providing new insights for therapeutic ap-
proaches to OCA4.
Materials and Methods
Cell culture and materials
The human melanoma MNT-1 cell line was kindly provided by Dr. Ai-Young Lee at Dongguk
University, who originally received it as a gift from Dr. Vincent J. Hearing at National Institutes
of Health, Bethesda, Maryland, USA [42]. The cells were cultured at 37°C in MEM (Gibco,
Carlsbad, CA, USA) containing 20% FBS, 10% DMEM (Lonza, Basel, Switzerland), 20 mM
HEPES and antibiotics. The WM266-4 human melanoma cells were obtained from the Ameri-
can Type Culture Collection (ATCC, Manassas, VA, USA). The SK-MEL-1, SK-MEL-2,
SK-MEL-3, and SK-MEL-5 human melanoma cell lines were obtained from the Korean Cell
Line Bank (KCLB, Seoul, Korea). Those cells were maintained at 37°C in RPMI1640 medium
(Gibco) containing 10% FBS and antibiotics. Normal human melanocytes (Cascade Biologics,
Portland, OR, USA) were cultured in M254 medium (Cascade) containing human melanocyte
growth supplement-2 (Cascade). Endo H and PNGase F were purchased from New England
Biolabs (Hitchin, UK).
Determination of melanin levels and the L-DOPA oxidase activity assay
of tyrosinase
Cell pellets were dissolved in 1 N NaOH for 1 hour at 80°C. The melanin levels were deter-
mined by measuring the absorbance at 450 nm. For the L-DOPA oxidase activity assay of ty-
rosinase, the cells were harvested with 1% NP-40 in PBS and clarified by centrifugation for 20
minutes at 16,000 ×g. The supernatants were incubated with 2 mg/ml L-DOPA for 1 hour, and
the absorbance at 450 nm was measured.
Western blot analysis and fluorescence microscopy
Cells were lysed in a buffer containing 0.05 M Tris-HCl (pH 7.5), 0.15 M NaCl, 0.01 MMgCl2,
1% NP-40 and a protease inhibitor cocktail (Sigma, St. Louis, MO, USA) and were subjected to
centrifugation. The protein content was quantified using the BCA assay. An aliquot of 10–
20 μg of protein was loaded into each well of an SDS-PAGE gel. For immunoblotting, the
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SDS-PAGE gel was electroblotted to a PVDF membrane. The following antibodies were used:
anti-MATP (Abnova, Taipei, Taiwan); anti-MATP F-4 (Santa Cruz Biotechnology, Santa
Cruz, CA, USA); anti-MATP H-130 (Santa Cruz Biotechnology); anti-EEA1 (Abcam, Cam-
bridge, UK); anti-TYRP-1, anti-LAMP1, anti-TNG46, anti-TYRP-2, and anti-GAPDH (Santa
Cruz Biotechnology); anti-Tyr (Upstate Biotechnology, Lake Placid, NY, USA); and anti-
TA99; anti-HMB45 (GenTex, Irvine, CA, USA). The MATP recombinant protein (Abnova)
was purchased and used for pre-absorption of anti-MATP antibody (Abnova). For fluores-
cence microscopy, cells were cultured on Lab-Tek chamber slides (Nunc, Waltham, MA, USA)
and then fixed with 4% paraformaldehyde in PBS, permeabilized with 0.1% Triton X-100 in
PBS containing 1% BSA for 5 minutes, and incubated with each antibody. Fluorescence was de-
tected after secondary staining with the Alexa Fluor 488-conjugated F(ab')2 fragment of goat
anti-mouse IgG (Invitrogen) and the Alexa Fluor 594-conjugated F(ab')2 fragment of goat
anti-rabbit IgG (Invitrogen).
siRNA and shRNA transfection
MNT-1 cells were transiently transfected with 100 nM ON-TARGETplus SMARTpool siRNA
(Thermo Fisher Scientific, Waltham, MA, USA) using Lipofectamine RNAimax (Invitrogen)
according to the manufacturer’s instructions. For the shRNA-expressing stable cell line, a
MATP shRNA plasmid was constructed using the MATP sequence (5’-GUACGAGUAUG-
GUUCUAUC-3’). After transfection with this plasmid, selection was performed for 2 weeks
with 200–1000 μg/ml zeocin (Genolution, Seoul, Korea) according to the manufacturer’s
instructions.
Quantitative real-time PCR (RT-qPCR)
Total RNA (1-2-μg) was reverse-transcribed into cDNA using ReverTra Ace (Toyobo, Osaka,
Japan) and an oligo(dT) primer. The gene expression analysis was performed using TaqMan
Universal Master Mix and TaqMan Gene Expression Assays (Applied Biosystems, Foster City,
CA, USA). The primers are listed in S1 Table.
Transmission electron microscopy
Confluent flasks of MNT-1 cells were fixed using Karnovsky fixative (Electron Microscopy Sci-
ences, Hatfield, PA, USA) for 30 minutes at RT, harvested by centrifugation and then embed-
ded in a low-melting-point agarose matrix (Sigma). After washing with PBS, the agarose-
embedded cells were post-fixed in 2% osmium tetroxide and stained with uranyl acetate. Then,
the specimens were dehydrated through a graded ethanol series and embedded in Embed-812
(Electron Microscopy Sciences) at 60°C for 72 hours. Ultrathin sections (approximately 70–90
nm) were stained using uranyl acetate and lead citrate and then observed using a transmission
electron microscope (TEM), JEM-1200 EX (Joel, Tokyo, Japan).
DAMP assay
The Acidic Granule kit was purchased from Oxford Biomedical Research (Oxford, MI, USA).
Cells were incubated with 30 μMDAMP [N-(3-((2,4-dinitrophenyl)amino)propyl)-N-(3-ami-
nopropyl)methylamine], Oxford Biomedical Research) for 30 minutes, fixed with 3% (wt/vol)
paraformaldehyde and washed with 50 mM ammonium chloride. After permeabilization with
0.1% Triton X-100 in PBS, an anti-DNP antibody (Oxford Biomedical Research) was added ac-
cording to the manufacturer’s instructions.
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Statistical analysis
A two-tailed Student’s t-test was used to analyze the differences between two groups.
Supporting Information
S1 Fig. The expression of MATP protein in melanotic cells. The expression of MATP protein
in primary melanocytes and in various melanoma cell lines was analyzed by western blotting
using two anti-MATP antibodies, F-4 (upper panel) and H-130 (lower panel).
(TIF)
S2 Fig. The MATP protein is located in the melanosomes.MNT-1 cells were stained with
anti-HMB45 or anti-TA99 antibodies together with an anti-MATP (H-130) antibody. The
inset is magnified. Scale bars = 10 μm.
(TIF)
S3 Fig. The effect of MATP-KD on the expression of melanogenesis-related genes. The
mRNA expression levels of melanogenesis-related genes in MNT-1 cells were analyzed by RT-
qPCR at day 4 post-treatment of MATP siRNA. The data are representative of three indepen-
dent experiments (, P< 0.005). TYR, tyrosinase; TYRP-1, tyrosinase related protein-1;
PMEL17, premelanosome protein 17; MITF, microphthalmia-associated transcription factor.
(TIF)
S4 Fig. Deglycosylation assay of tyrosinase. The lysates of MNT-1 cells treated with scram-
bled or MATP siRNAs were incubated with or without Endo H for 24 hours, and tyrosinase
protein was detected using an anti-TYR antibody.
(TIF)
S1 Table. Primer list used for quantitative real-time PCR analysis.
(XLSX)
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